Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

anti-HER3/topoisomerase I inhibitor antibody-drug conjugate

Any antibody-drug conjugate (ADC) that is composed of a monoclonal antibody directed against human epidermal growth factor receptor 3 (HER3; ErbB3) and conjugated to a cytotoxic DNA topoisomerase I inhibitor.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	anti-HER3/Top-I inhibitor ADC anti-HER3/TopIi ADC anti-HER3/topoisomerase I inhibitor ADC

anti-HER3/topoisomerase I inhibitor antibody-drug conjugate

Search NCI's Drug Dictionary